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942Objective: This study defined long-term results of a policy of single-stage repair of interrupted aortic arch with
end-to-side anastomosis.
Methods: Records of 112 consecutive patients undergoing interrupted aortic arch repair between 1985 and 2007
were reviewed. Single-stage repair was performed in 95 patients, with 90 having end-to-side repair.
Results: There were 11 in-hospital deaths (10%). Twelve patients needed arch reintervention during the same
hospital stay: 7 for residual arch obstruction and 5 for left main bronchus obstruction. Nine patients were unavail-
able for follow-up. After a mean of 10  7 years, 6 late deaths occurred, for 18-year survival of 92% (95% con-
fidence interval [CI], 84%–97%). Patients with end-to-side anastomoses had better 18-year survival (97%, 95%
CI, 87%–99%, vs 74%, 95%CI, 44%–89%, P<.01). After discharge, 19 patients underwent further aortic arch
intervention. The only factors predictive of late arch reintervention were technique other than end-to-side (P<
.001) and reoperation for left outflow tract obstruction. Freedom from arch reintervention after end-to-side repair
was 78% at 18 years (95%CI, 59%–89%). Another 16 patients had significant residual obstruction. The 18-year
freedom from hypertension was 88% (95% CI, 72%–95%).
Conclusions: Single-stage repair with end-to-side anastomosis seems the best approach for most neonates with
interrupted aortic arch, because it provides relief of the arch obstruction with low early mortality. After 2 decades
of experience with this approach, incidence of late hypertension seems minimal. The need for further arch rein-
tervention warrants close follow-up of these patients. (J Thorac Cardiovasc Surg 2010;139:942-9)Earn CME credits at
http://cme.ctsnetjournals.org
The outcomes of patients undergoing single-stage repair of
interrupted aortic arch without graft interposition have
been well delineated only for the first years after repair.1-11
Little is known yet regarding the late outcomes of these pa-
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The Journal of Thoracic and Cardiovascular Surgof recurrence of arch obstruction and prevalence of hyper-
tension. During the last 2 decades, our team has consistently
adopted a policy of single-stage repair of interrupted aortic
arch with end-to-side anastomosis. We review here our ex-
perience with this approach.MATERIALS AND METHODS
The study was approved by the hospital’s Ethics and Human Research
Committee. The end-to-side repair of interrupted aortic arch was introduced
in 1985 in the Royal Children’s Hospital in Melbourne, Australia. The re-
cords of all patients who had undergone an interrupted aortic arch repair
from January 1985 to June 2007 were reviewed.
Patients
There were 112 patients, comprising 100 operated on as neonates (age,
<30 days) and 12 as infants. The characteristics of the patients are given
in Table 1.
Shunting occurred at the level of the great vessels through an aortopul-
monary window in 4 patients and at the ventricular level in 91 patients
(13 truncus, 7 double-outlet right ventricle, 10 transposition of the great
arteries, 2 atrioventricular septal defect, and 59 isolated ventricular septal
defects [VSDs]). The remaining 16 patients had functionally univentricular
heart. A single patient with interruption type A with Williams syndrome and
supravalvular aortic stenosis had no identified shunting.
Thirty-five of the 37 patients found to have 22q11 deletion had a type B
interruption. Three patients (1 each) had Charge, Kabuki, and Schprintzen
syndromes. Before surgery, 33 patients (29%) required the combination
of mechanical ventilation, prostaglandin infusion, and inotropic support.ery c April 2010
Abbreviations and Acronyms
CI ¼ confidence interval
LVOT ¼ left ventricular outflow tract
VSD ¼ ventricular septal defect
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Ninety-five patients (85%) underwent end-to-side repair with cardio-
pulmonary bypass by sternotomy; the remaining 17 (15%) underwent
some other procedure. The technique of end-to-side repair was consistent.
Through the median sternotomy, the head vessels and the descending
aorta were extensively dissected. With cardiopulmonary bypass, during
cooling, the first 3 pairs of intercostal arteries were cauterized and divided.
Before 2000, all patients underwent arch repair during deep hypothermic
circulatory arrest. Since 2000, all patients have undergone operation with
selective cerebral perfusion. For selective cerebral perfusion, a straight,
wire-reinforced cannula is inserted in the ascending aorta, just below
the emergence of the innominate artery. After cooling to 25C, the aorta
is crossclamped and cardioplegia administered in the aortic root. The ar-
terial cannula is advanced in the innominate artery and snared in position.
The flow is reduced to 10% to 25% of the estimated full flow of the pa-
tient, according to the continuous monitoring of the right radial arterial
reading. The remaining head vessels are then snared to proceed with
the repair. All ductal tissue is extensively resected. An incision is made
in the posterior aspect of the ascending aorta and the transverse arch, op-
posite the emergence of the innominate artery (Figure 1). After comple-
tion of the repair and deairing of the arch, the cannula is repositioned
in the ascending aorta and full cardiopulmonary bypass reestablished.
Of the 17 patients who did not undergo end-to-side repair, 10 underwent
operation by thoracotomy between 1985 and 1997. Three of these underwent
left subclavian flap repair, 4 underwent end-to-end anastomosis, 1 underwent
end-to-side repair, and 2 underwent 8-mm GORE-TEX graft interposition
(W. L. Gore & Associates, Inc, Flagstaff, Ariz). The remaining 7 patients un-
derwent operation by sternotomy with cardiopulmonary bypass. Four pa-
tients underwent concomitant Damus procedures; in these patients, the 2
segments of aorta were approximated and the concavity of the arch was re-
constructed with patches of autologous pericardium3 or homograft pericar-
dium.1 One patient had a patch added to an end-to-side repair, 1 had a 10-
mm aortic homograft interposition, and 1 had a left subclavian flap repair.
When not used in a flap repair, the left subclavian artery was left intact.
Single-stage repair was performed in 97 patients (87%), with 90 of these
undergoing end-to-side repair by sternotomy. The associated procedures are
listed in Table 1.
Subaortic Stenosis
Thirty-five patients had suspected restrictive left ventricular outflow tract
(LVOT). Relief of the restriction was determined by inspection of the
LVOT. Twenty-two patients with LVOT restriction underwent no interven-
tion at this level. One patient with 2 morphologic ventricles and 3 with sin-
gle-ventricle morphology underwent Damus procedures. One patient
underwent an arterial switch procedure, and the remaining 8 underwent re-
section of the obstructed LVOT (7 resections of the conal septum and 1 of
a fibrous shelf).
Outcomes
In-hospital mortality was defined as death before discharge from the hos-
pital or within 30 days afterward. Late arch obstruction was noted for pa-
tients who underwent arch reintervention, were found to have a gradient
greater than 20 mm Hg between the arm and leg, or had an echocardiograph-
ically identified peak gradient greater than 25 mm Hg in the descending
aorta. Patients were considered to be hypertensive when specifically de-The Journal of Thoracic and Cascribed as hypertensive by the referring cardiologist, when systolic blood
pressure was greater than 133 mm Hg, or when diastolic blood pressure
was greater than 78 mm Hg.12
Statistical Analysis
Data were reported as mean  SD or as median with interquartile range.
All tests were 2-tailed. All preoperative and perioperative variables were
tested by univariate analysis for prediction of in-hospital mortality, and sig-
nificant factors were entered into a stepwise logistic regression analysis. The
list of analyzed parameters is given in Appendix 1. Kaplan–Meier survival
analysis and hazard function analysis were performed for time-related
events (late survival, arch reintervention, and recurrent arch obstruction).
Risk factors for time-related events were tested by the Cox proportional haz-
ards method. All data were analyzed with Stata version 10.0 (StataCorp LP,
College Station, Tex).
RESULTS
In-Hospital Mortality
There were 11 early deaths, for an in-hospital mortality
of 10%: 6 of 38 patients with type A interruption (16%)
and 5 of 72 with type B (7%, P ¼ .13). The causes of death
were low-output syndrome (n ¼ 6), pulmonary hypertension
(n ¼ 3), pneumonia (n ¼ 1), and Staphylococcus aureus
endocarditis (n¼ 1). Two of the patients who died of low-out-
put syndrome had residual arch obstruction diagnosed. The
postoperative course of 1 patient who died of pulmonary hy-
pertension was complicated by compression of the left bron-
chus. Seven of the 90 patients who had undergone a one-
stage end-to-side repair (8%) and 4 of the 22 operated with
a different technique (18%) died (P¼ .15). Two of the 13 pa-
tients born with truncus arteriosus and 3 of the 16 with a func-
tionally univentricular heart also died. By univariate analysis,
only lack of VSD closure predicted mortality (P< .05).
Postoperative Complications
Ventilation time, intensive care unit stay, and hospital stay
were available for 81 patients. The median ventilation time
was 4 days (2–7 days, end-to-side repair 4 days [2–7 days]
and other 4 days [2–5 days], P ¼ .19), the median intensive
care unit stay was 5 days (4–11 days, end-to-side repair 5
days [4–10 days] and other 8 days [3–20 days], P ¼ .14),
and the median hospital stay was 5 days (11–30 days, end-
to-side repair 14 days [10–28 days] and other 29 days
[14–35 days], P ¼ .23).
Four of the 95 patients who underwent end-to-side repair
and 3 of the 17 who underwent another procedure needed an
early arch reintervention after a median of 29 days (9–43
days). Three of them underwent balloon dilatation. Two pa-
tients with previous truncus arteriosus repair underwent
patch augmentation of the repair. The 2 remaining patients
had univentricular hearts and needed reoperative correction
of the Damus procedure with patch repair of the arch. One of
them subsequently died.
Left main bronchus compression was identified after re-
pair in 7 patients (6 end-to-side repairs, 3 associated with
truncus arteriosus). Five of these patients requiredrdiovascular Surgery c Volume 139, Number 4 943
TABLE 1. Patient characteristics
Variables Total (n ¼ 112) End-to-side (n ¼ 95) Other (n ¼ 17) P value
Sex (male/female ratio) 59:53 48:47 11:6
Type of interruption (no.)
Type A 38 (34%) 26 (27%) 12 (71%) <.001
Type B 72 (64%) 67 (71%) 5 (29%) <.001
Type C 2 (2%) 2(2%) 0 (0%) .546
Associated cardiac anomalies (no.)
Ventricular septal defect 87 (78%) 76 (80%) 11 (65%) .163
Univentricular heart 16 (14%) 8 (8%) 8 (47%) <.001
Double-inlet left ventricle 6 (5%) 5 (5%) 1 (6%) .917
Truncus arteriosus 13 (12%) 12 (13%) 1 (6%) .424
Transposition of great arteries 11 (10%) 7 (7%) 4 (24%) <.05
Double-outlet right ventricle 7 (6%) 4 (4%) 3 (18%) <.05
Aortopulmonary window 4 (4%) 4 (4%) 0 (0%) .389
Subaortic stenosis 35 (31%) 29 (31%) 6 (35%) .696
Bicuspid aortic valve 24 (21%) 24 (25%) 0 (0%) <.05
Aberrant right subclavian artery 22 (20%) 21 (22%) 1 (6%) .121
Noncardiac anomaly (22q11 deletion, no.) 37 (33%) 36 (38%) 1 (6%) <.05
Clinical symptoms (no.)
Renal failure 50 (45%) 41 (43%) 9 (53%) .940
Necrotizing enterocolitis 5 (5%) 5 (5%) 0 (0%)
Preoperative management (no.)
Prostaglandin infusion 84 (75%) 73 (58%) 11 (65%) .344
Mechanical ventilation 54 (48%) 50 (53%) 4 (24%) .171
Inotropic support 44 (39%) 40 (42%) 4 (24%) .575
Age at operation (d) .911
Median 6 6 6
Interquartile range 4–11 4–12 3–11
Associated procedures (no.)
Ventricular septal defect closure 74 (66%) 71 (75%) 3 (18%) <.001
Left ventricular outflow tract obstruction relief 8 (7%) 7 (7%) 1 (6%) .827
Damus shunt 11 (10%) 8 (8%) 3 (18%) .239
Pulmonary artery banding 12 (11%) 6 (6%) 6 (35%) <.001
Operation type (1-stage/2-stage ratio) 97:15 90:5 7:10 <.001
Cardiopulmonary bypass
Used (no.) 101 (90%) 93 (98%) 8 (47%) <.001
Mean duration (min, mean  SD) 138  67 136  67 166  69 .228
Circulatory arrest
Used (no.) 86 (77%) 78 (82%) 6 (35%) .291
Mean duration (min, mean  SD) 37  17 37  18 36  13 .921
Minimum temperature (C, mean  SD) 18  5 18  4 19  9 .786
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conduit, 1 required aortic homograft interposition, and 2 re-
quired aortopexy. No preoperative or perioperative variables
were significantly associated with a risk of postoperative
bronchial obstruction. Nine patients needed another reoper-
ation to perform the following 10 cardiac procedures: adjust-
ment of pulmonary artery banding (n¼ 3), relief of residual
LVOT obstruction (n ¼ 2), VSD closure (n ¼ 1), atrioven-
tricular septal defect repair (n¼ 1), arterial switch procedure
and right modified Blalock-Taussig shunt (n¼ 1), Norwood
procedure (n¼ 1), and cavopulmonary anastomosis (n¼ 1).
Additional complications encountered were diaphragm pa-
ralysis necessitating plication (n ¼ 3) and complete heart944 The Journal of Thoracic and Cardiovascular Surgblock necessitating pacemaker implantation after VSD
closure (n ¼ 2). None of the patients who required enlarge-
ment of the LVOT required pacemaker implantation.
Late Outcomes
Survival. Eighty-two of the 101 immediate survivors left
the hospital with an end-to-side repair and 19 with another
procedure. Nine of these 101 hospital survivors were un-
available for follow-up (6 end-to-side repairs). Concurrent
follow-up (2004–2008) was 79% (80/101 patients). Mean
follow-up was 10 7 years. Six patients died within 5 years
of the arch repair (3 end-to-side repairs). Causes of death
were sudden cardiac death (n ¼ 2), reoperative surgery forery c April 2010
FIGURE 1. End-to-side repair.
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left main bronchus compression (n ¼ 1), and postvaccina-
tion anaphylactic shock (n ¼ 1). Hospital survivors of inter-
rupted aortic arch repair achieved an 18-year survival of
92% (95% confidence interval [CI], 84%–97%). Signifi-
cant variables affecting late survival are listed in Appendix
2. There were no independent predictors of late mortality.
(Figure 2). The 18-year survivals were 97% (95% CI,
87%–99%) after end-to-side repair and 74% after the other
procedures (95% CI, 44%–89%; P< .05).
Reintervention not related to the aortic arch. Three of
the 8 patients who underwent resection of LVOT obstruction
and 3 of the 22 with suspected obstruction who did not un-
dergo any resection during their first hospital stay needed
later resection of the LVOT obstruction after a mean of 4
 4 years. In a single patient among those who had no initial
resection of the LVOT, the intervention consisted of a Ross–
Konno procedure. An additional 22 patients underwent the
following 28 procedures: replacement of right ventricle–pul-
monary artery conduit (n¼ 9), bidirectional cavopulmonary
shunting (n¼ 8), Fontan operation (n¼ 6), pacemaker inser-
tion (n ¼ 4), and arterial switch procedure (n ¼ 1).
Arch reintervention. Nineteen patients needed arch rein-
tervention after a mean of 8  6 years. Eleven of theseFIGURE 2. Kaplan–Meier survival graph for 92 of 101 hospital survivors
of repair (9 patients unavailable for follow-up).
The Journal of Thoracic and Capatients were among the 78 discharged from the hospital
with an end-to-side repair. Eleven patients underwent bal-
loon dilatation of the arch, and 1 underwent balloon dilata-
tion and stenting. Three of these procedures failed, and the
patients needed subsequent surgery. Seven patients were
sent directly to surgery. The 18-year freedom from aortic
arch reintervention was 69% (95% CI, 52%–81%). Inde-
pendent predictors of arch reintervention were undergoing
a procedure other than an end-to-side repair (P < .001)
and undergoing reoperation for LVOT obstruction (P <
.05). The 18-year freedom from arch reintervention after
end-to-side repair was 78% (95% CI, 59%–89%; Figure 3
and Appendix 2).
Arch obstruction. A total of 33 patients were considered to
have recurrent arch obstruction. The 18-year freedom from
aortic arch obstruction was 46% (95% CI, 31%–61%).
Eighteen years after end-to-side repair, the freedom from
arch obstruction was 51% (95% CI, 34%–66%). The mul-
tivariate Cox regression analysis revealed that patients with
an aberrant right subclavian artery, those operated on with
a procedure other than end-to-side anastomosis, and those
needing further relief of LVOT obstruction had higher chan-
ces of recurrent arch obstruction (P< .05; Figure 4 and
Appendix 2).
Late hypertension. Only 5 patients were found to be
hypertensive at last follow-up. The 18-year freedom from
hypertension was 88% (95% CI, 72%–95%).
DISCUSSION
Currently, the best surgical technique to repair interrupted
aortic arch remains disputed.1 Most favor a direct anastomo-
sis between the interrupted segments of aorta.2-5 The benefits
of the addition of a patch to the repair remain controversial.6-
8 Some have also recommended the use of a flap made from
the stump of a carotid or subclavian vessel.9 Although most
centers currently favor single-stage repair of associated car-
diac lesions, some still advocate 2-stage repairs under all or
selected circumstances.3,5,7,9-11 Each center has usually fa-
vored only one of these multiple surgical approaches on
the basis of the personal preferences and past experiencesFIGURE 3. Kaplan–Meier graph of freedom from arch reintervention for
92 of 101 hospital survivors of repair (9 patients unavailable for follow-up).
rdiovascular Surgery c Volume 139, Number 4 945
FIGURE 4. Kaplan–Meier graph of freedom from arch obstruction for 92
of 101 hospital survivors of repair (9 patients unavailable for follow-up).
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never be evenly distributed among different surgical ap-
proaches and because in multicentric studies noticeable dif-
ferences have been noted among outcomes at different
centers, it will remain difficult to prove the superiority of
any given approach through the analysis of early outcomes.6
Currently, there are only scarce reports on outcomes of inter-
rupted aortic repairs beyond the first decade after surgery. At
a time when most surgeons achieve similar early survivals
for these patients, the best demarcation of the superiority
of a technique of arch repair might arguably be better late
outcomes.4,5,11 Recurrent obstruction at the level of the re-
pair has been demonstrated. Also, although there are increas-
ing concerns regarding late occurrence of systemic
hypertension in patients who have undergone conventional
repair of coarctation, nothing is yet known regarding the in-
cidence of hypertension among patients undergoing repair of
interrupted aortic arch.12-14
The repair of interrupted aortic arch by direct anastomosis
without interposition of graft material has remained our fa-
vorite approach since 1985.15 We believe that the long-
term outcomes of our patients may serve as a benchmark
for the expectations for those operated on with this particular
technique.Limitations
This is a retrospective review of our experience during
a long period. The results presented here may not accurately
reflect today’s achievements. Single-stage repair with an
end-to-side anastomosis performed through a sternotomy
was obviously favored among our patients. This series there-
fore determines what can be achieved with this approach but is
limited in its analysis of the comparative benefits of the differ-
ent surgical techniques used. The other techniques were used
early in our experience, when patient management may have
been less than optimal. Use of another technique may also
have reflected the technical difficulties encountered or the
complexity of the associated cardiac lesions. These proce-
dures were performed during an extended period, and the946 The Journal of Thoracic and Cardiovascular Surgresults observed may reflect this fact. In particular, because
cardiac arrest and selective cerebral perfusion were used in dif-
ferent periods, this study cannot provide an adequate compar-
ison of these approaches. Finally, the determination of the late
incidence of systemic hypertension depends on the criteria
used to define hypertension. Because of the design of the
study, we had no access to the height or the body surface
area of the patients at last examination, and we therefore we
could not use normative data. It is possible that 24-hour blood
pressure monitoring and exercise testing of the patients would
have detected more hypertension among these patients than
we did. In addition, the results of late hypertension and arch
obstruction reported here were extracted from letters of refer-
ring cardiologists, and it is unclear whether in some cases the
existence of lesions of the origin of the subclavian vessels may
have masked the real incidence of these complications.
Early Outcomes
Our in-hospital mortality of 10% is among the lowest re-
ported for this group of patients.2,9 The technique of end-to-
side repair was feasible without any patch interposition in
most instances. A key aspect of the technique is the exten-
sive dissection of the descending aorta. To avoid left main
bronchus compression, sufficient space should be left under
the arch concavity, and care should be taken to avoid per-
forming the implantation of the descending aorta too low
on the ascending aorta. Left main bronchus compression is
a known complication of the technique.5,11 In 3 of the 6 oc-
currences of this complication, the patient had truncus arte-
riosus. Today, whenever the space left under the arch may
become too narrow, we tend to perform the anastomosis
more distally on the arch and at times, if deemed necessary,
complete the repair with the addition of a patch to alleviate
the risk of bronchial compression. Patch augmentation has
already been shown to improve survival after aortic arch re-
pair.6,7 It was performed so infrequently in this series, how-
ever, that its beneficial impact cannot be evaluated. In recent
years, we have also more frequently performed aortic arch
patch augmentation in patients with a functionally single
ventricle requiring a concomitant Damus and shunting pro-
cedures, because the size of the Damus repair may further
limit the space under the concavity of the arch.
Single-stage repair has been our favorite approach since
the beginning of our experience. Although in this study its
benefits could not be specifically compared with those of
a 2-stage approach, we believe that this practice also contrib-
uted to our low in-hospital mortality.
Subaortic LVOT obstruction is an intrinsic component of
interrupted aortic arch disease. Its diagnosis is difficult to es-
tablish with certainty before completion of the repair. It has
been associated with higher mortality.4,10 As published pre-
viously, LVOT obstruction had no noticeable impact on the
early outcomes of our patients.16 Interestingly, repair of as-
sociated anomalies did not appear to be a risk factor forery c April 2010
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lack of VSD closure at the time of repair, which we believe
selected the less severe cases with shunting restricted to a sin-
gle VSD.
Late Outcomes
The most striking finding of this study is the high inci-
dence of recurrent arch obstruction and arch reintervention.
Eighteen years after arch repair, half of the patients had re-
current obstruction of the aortic arch, and a quarter needed
arch reintervention. This high rate of obstruction is in con-
trast with the low rate of hypertension at last follow-up. Al-
though this risk is important to convey to patients’ families,
it seems difficult to determine the best way to improve these
results. There was a slight trend toward improvement be-
tween operative eras, but it seems unlikely that we are
now performing better operations than in the past. Patients
operated on by sternotomy with an end-to-side repair had
fewer reinterventions and recurrent obstructions than those
operated with other techniques. We should nonetheless not
deduce from this finding that more extensive use of this tech-
nique will prevent recurrent obstruction, because the patients
were obviously not equally distributed between groups. Un-
der exceptional circumstances, it may seem reasonable to
add a patch to the repair whenever undue tension is sus-
pected. We would not recommend the addition of a patch
in all cases, because this would significantly increase the
length of the procedure and because the large proportion
of the patients surviving to adulthood without any obstruc-
tion should have a long-lasting result thereafter. The finding
that patients who had an aberrant subclavian artery had more
risk of recurrent obstruction may indicate how to perform the
repair better. The high incidence of aberrant subclavian ar-
tery in patients with interrupted aortic arches had already
been noticed.17 In this instance, some have reported difficul-
ties in performing a direct anastomosis.8,18 We believe that
a larger amount of ductal tissue is present in the presence
of an aberrant subclavian artery. Unless the artery is sacri-
ficed, which has not been our usual practice, there is an in-
creased risk of leaving remnants of ductal tissue in the
area of the anastomosis, contributing to the subsequent nar-
rowing of the area. This finding encourages us to perform
drastic resection of all ductal tissue before the completion
of the repair. We believe that proximal ligation of the right
subclavian artery, with or without its reimplantation, may
be considered when its anomalous implantation seems to
compromise the repair. Patients who required reoperation
for LVOT obstruction had higher risk of late arch obstruc-
tion and arch reintervention. This is probably because re-
striction of the LVOT correlates with more significant
disease of all left-sided structures, including the aorta.
Only a limited number of patients with LVOT obstruction
required reintervention, so no technical changes should be
offered for this subset of patients.The Journal of Thoracic and CaCONCLUSIONS
In conclusion, we believe single-stage repair with end-to-
side anastomosis to be the optimal approach for most neo-
nates born with interrupted aortic arch. This repair provided
long-lasting relief of arch obstruction with low early mortal-
ity. After 2 decades of experience with this approach, the in-
cidence of late hypertension seems minimal. The need for
further arch reintervention warrants close follow-up of these
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Dr Frank L. Hanley (Stanford, Calif). This is a nice study. Mo-
han Reddy sends his regards and also apologizes for not being here;
he was unable to leave because of coverage issues at home.
As you mentioned, there are many, many ways to skin this cat. It
just so happens that we skin it exactly the same way you do. We
also do a midline sternotomy with intracardiac repair and end-to-
side arch anastomosis. And I don’t think you emphasized it here,
but you also have used antegrade cerebral perfusion since 2000.
We also have used antegrade cerebral perfusion exclusively since
1992. So we have the exact same approach that you do.
Long-term follow-up of interrupted aortic arch repair is not well
documented in the literature, so your study is clearly an important
addition. And with a consistent approach for more than 20 years,
your late information on recurrence rates and hypertension, ac-
knowledging the interpretation issues that you yourself mention,
are informative data. Also, just as an aside, it’s nice to have a subject
that we agree on.
You included all your patients with interrupted aortic arch, in-
cluding those with single ventricles, and all types of VSDs. But
what you didn’t do in the analysis, and all the information was there
for you to pull out, is isolate as a separate subanalysis the ‘‘typical’’
type A or B interrupted arch with posterior malaligned conoventric-
ular VSD. I believe that 59 patients in your total series fall into this
category. Analysis of this somewhat homogeneous subgroup
would allow some comparison with other studies reporting on
this ‘‘typical’’ interrupted arch group. Did you do any of that
kind of analysis?
Dr d’Udekem. Actually, we did not do a separate analysis of the
patients with malaligned VSDs in the frame of this long-term fol-
low-up study. What we did do is precisely take this group of pa-
tients and perform much more detailed analysis.
Dr Hanley. So playing that same idea out a little bit further, how
do you manage the problematic LOVT in double-ventricle patients
with interrupted aortic arch? I noticed that you had 6 patients who
underwent some resection of the subaortic area at the initial opera-
tion, but you also did a half dozen or so Damus procedures. Specif-
ically, were any of those Damus procedures done as an alternative
to direct LVOT resection in those patients with isolated VSD and
difficult subaortic areas?
Dr d’Udekem. As far as I remember, all of the Damus proce-
dures were performed in cases of single-ventricle pathology.948 The Journal of Thoracic and Cardiovascular SurgDr Hanley. If you have a really difficult subaortic area that you
don’t want to address, a Damus procedure and a conduit provide
a way out. We have done that occasionally, but very, very rarely.
So when you would resect and when would you do a Damus pro-
cedure?
Dr d’Udekem. I’m sure that it’s an option that we would con-
sider in very difficult subaortic stenosis, but it’s not an option
that we’ve done often. In this particular study, I cannot remember
that a Damus procedure was done for subaortic obstruction, but
it’s definitely an option we would still consider today.
Dr Hanley. Do you have objective criteria for when you address
the LVOT? Because, of course, the preoperative physiology is non-
predictive. Do you have an anatomic criterion or set of criteria that
you use?
Dr d’Udekem. The way we do it is very much like our predeces-
sors. We go in and we have a look. And sometimes we do nothing, or
resect, or take another step on the basis of the intraoperative findings.
Dr Hanley. Final question. Your incidence of late reoperation is
roughly half your incidence of late identification of some arch ob-
struction. What criteria do you use for intervention versus observa-
tion when you have identified late obstruction?
Dr d’Udekem. We have, to be honest, no strict criteria. We de-
cide on a case-by-case basis. Clearly, however, if we have a gradient
above 20 to 25 mm Hg, we would recommend balloon dilatation or
even surgical intervention. I think the evidence is accumulating that
if you don’t have the right arch geometry, even with low gradients,
you should do something to this arch, not hesitating to reoperate.
And I think in the past few years our threshold for reoperation on
an abnormal arch has gotten lower.
Dr Joseph J. Amato (Chicago, Ill). This was an excellent study
that you presented. From your diagram and from your first comment,
you stated that you did extensive resection. I assume that you divided
some of the intercostal arteries as the aorta was pulled upward. How
many intercostals were divided? If you did dissect any of them, how
many? Did you have any incidence of paralysis or at least paresis?
Drd’Udekem.When I was in Melbourne, I got the clear message
that for all this type of work I had to dissect the first 3 pairs of inter-
costal arteries. Dissect, cauterize, and divide the first 3 pairs of inter-
costal arteries, and I have religiously done so every time since. We
do that for Norwood procedures as well. I’ve never seen and never
heard about either paraplegia or paresis in that setting.
Dr Amato. Excellent. Thank you very much.ery c April 2010
APPENDIX 1. Collected variables
Time frame Variables
Preoperative Sex
Age at operation
Type of interruption
Associated cardiac condition
Bicuspid valve
Aberrant right subclavian artery
Subaortic stenosis
Univentricular heart
22q11 deletion
Prostaglandin infusion
Mechanical ventilator
Inotropic support
Renal failure
Necrotizing enterocolitis
Perioperative Era (1985–1995 vs 1996–2007)
End-to-side/other repair
Associated procedures
Graft interposition
Left ventricular outflow tract obstruction relief
Thoracotomy/sternotomy
1-stage/2-stage repair
Bronchus compression
Cardiopulmonary bypass time
Cardiac arrest time
Selective cerebral perfusion
Postoperative Bronchus compression
Arch obstruction
Arch reoperation
Balloon dilatation
Other cardiac reoperations
APPENDIX 2. Risks factors for late outcomes among hospital
survivors
P value
Univariate Multivariate
Late mortality
Double-outlet right ventricle .013
Pulmonary arterial banding .017
Thoracotomy .025
2-Stage repair .025
Bronchus compression .006
Other than end-to-side .009
Arch reintervention
Thoracotomy .002
Other than end-to-side .003 <.001
Interposition conduit <.001
Further LVOTO relief .006 .027
Arch obstruction
Aberrant right subclavian artery .036 .047
Era 1985–1995 .048
Thoracotomy .01
Other than end-to-side .02 <.001
Interposition conduit .006
Further LVOTO relief .005 .028
LVOTO, Left ventricular outflow tract obstruction.
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